FDA Clears Factor VIII Product Kovaltry for Hemophilia AFDA Clears Factor VIII Product Kovaltry for Hemophilia A

Studies show routine prophylaxis with Kovaltry helps controls bleeds and reduces frequency of bleeding episodes in children and adults with hemophilia A. FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news